Tracked deals
3
3 tracked deals across 2004-2025.
Milford, Massachusetts, United States
Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service—focused on regulated, high-volume testing environments to help advance the release of high-quality medicines and improve human health and well-being.
Tracked deals
3
3 tracked deals across 2004-2025.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
3 buyout
Last 2 years
Supporting Data
Waters Corporation has acquired Halo Labs, a venture-backed developer of the Aura imaging platform for subvisible and visible particle analysis used in cell, gene and protein therapy development and QA/QC. The deal brings Halo Labs' high-throughput, low-volume particle analysis technology into Waters' Wyatt Technology portfolio to expand Waters' analytical and bioprocessing testing capabilities for large-molecule therapies.
Waters Corporation agreed to acquire Wyatt Technology, a leader in light scattering instruments, software and related services, for $1.36 billion in cash. The acquisition (expected to close in Q2 2023) expands Waters' capabilities and exposure to bioanalytical characterization and large-molecule applications; Wyatt reported ~ $110 million in 2022 revenue and employs more than 200 people worldwide.
Waters Corporation completed the acquisition of NuGenesis Technologies, a Westborough, Massachusetts-based developer of laboratory informatics and SDMS products, for approximately $43 million. The purchase expands Waters' informatics product portfolio and strengthens its offering for scientific and pharmaceutical laboratories.
Turn tracked acquisition activity into an outreach-ready buyer list.